The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zharova M.E.

Pirogov Russian National Research Medical University

Doctor, what’s wrong with me?

Authors:

Zharova M.E.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2025;(1‑2): 36‑44

Read: 347 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Zharova ME. Doctor, what’s wrong with me? Non Nocere. New Therapeutic Journal. 2025;(1‑2):36‑44. (In Russ.)

 
ЭндоКард
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Nonalcoholic fatty liver disease.

Authors:

Zharova M.E.

Pirogov Russian National Research Medical University

Close metadata

References:

  1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980 Jul;55(7):434-438. 
  2. Lonardo A, Leoni S, Alswat KA, Fouad Y. History of Nonalcoholic Fatty Liver Disease. Int J Mol Sci. 2020 Aug 16;21(16):5888. https://doi.org/10.3390/ijms21165888
  3. Schaffner F, Thaler H. Nonalcoholic fatty liver disease. Prog Liver Dis. 1986;8:283-298. 
  4. Eslam M, Sanyal AJ, George J; International Consensus Panel. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology. 2020 May;158(7):1999-2014.e1.  https://doi.org/10.1053/j.gastro.2019.11.312
  5. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease – Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016 Jul;64(1):73-84.  https://doi.org/10.1002/hep.28431
  6. Maev I.V., Andreev D.N., Kucheryavy Y.A. Prevalence of non-alcoholic ffat disease liver in Russian Federation: meta-analysis. Consilium Medicum. 2023;25(5):313-319.  https://doi.org/10.26442/20751753.2023.5.202155
  7. Kucheryavy Yu.A., Cheremushkin S.V. Therapeutic efficacy evaluation of the reference drug ursodeoxycholic acid and its analogues in the biliary sludge dissolution: a meta-analysis. Consilium Medicum. 2022;24(12):860-864.  https://doi.org/10.26442/20751753.2022.12.201429
  8. Mao Q, Lin B, Zhang W, et al. Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives. Front Pharmacol. 2024 Mar 21;15:1371574. https://doi.org/10.3389/fphar.2024.1371574
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.